These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
379 related items for PubMed ID: 28646421
1. How safe and effective is denosumab for bone giant cell tumour? Errani C, Tsukamoto S, Mavrogenis AF. Int Orthop; 2017 Nov; 41(11):2397-2400. PubMed ID: 28646421 [Abstract] [Full Text] [Related]
2. Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone. Traub F, Singh J, Dickson BC, Leung S, Mohankumar R, Blackstein ME, Razak AR, Griffin AM, Ferguson PC, Wunder JS. Eur J Cancer; 2016 May; 59():1-12. PubMed ID: 26990281 [Abstract] [Full Text] [Related]
3. Giant cell tumour of bone in the denosumab era. van der Heijden L, Dijkstra PDS, Blay JY, Gelderblom H. Eur J Cancer; 2017 May; 77():75-83. PubMed ID: 28365529 [Abstract] [Full Text] [Related]
4. Risks and benefits of combining denosumab and surgery in giant cell tumor of bone-a case series. Müller DA, Beltrami G, Scoccianti G, Campanacci DA, Franchi A, Capanna R. World J Surg Oncol; 2016 Nov 04; 14(1):281. PubMed ID: 27809843 [Abstract] [Full Text] [Related]
6. [Denosumab may be a supplement to the surgical treatment of giant cell tumours of bone]. Sørensen AL, Hansen RL, Jørgensen PH. Ugeskr Laeger; 2016 Sep 05; 178(36):. PubMed ID: 27593237 [Abstract] [Full Text] [Related]
7. Is Treatment with Denosumab Associated with Local Recurrence in Patients with Giant Cell Tumor of Bone Treated with Curettage? A Systematic Review. Tsukamoto S, Tanaka Y, Mavrogenis AF, Kido A, Kawaguchi M, Errani C. Clin Orthop Relat Res; 2020 May 05; 478(5):1076-1085. PubMed ID: 31794487 [Abstract] [Full Text] [Related]
9. Denosumab does not decrease the risk of lung metastases from bone giant cell tumour. Tsukamoto S, Mavrogenis AF, Leone G, Righi A, Akahane M, Tanzi P, Kido A, Honoki K, Tanaka Y, Donati DM, Errani C. Int Orthop; 2019 Feb 05; 43(2):483-489. PubMed ID: 30099641 [Abstract] [Full Text] [Related]
12. Recurrent giant cell tumour of the maxillary sinus and pterygoid process treated with denosumab. Rosa D, Dias RB, Salvador JC, Borges A. BMJ Case Rep; 2018 Sep 08; 2018():. PubMed ID: 30196254 [Abstract] [Full Text] [Related]
13. Clinical and pathological results of denosumab treatment for giant cell tumors of bone: Prospective study of 14 cases. Deveci MA, Paydaş S, Gönlüşen G, Özkan C, Biçer ÖS, Tekin M. Acta Orthop Traumatol Turc; 2017 Jan 08; 51(1):1-6. PubMed ID: 27784623 [Abstract] [Full Text] [Related]
14. Current concepts in the treatment of giant cell tumour of bone. van der Heijden L, Dijkstra S, van de Sande M, Gelderblom H. Curr Opin Oncol; 2020 Jul 08; 32(4):332-338. PubMed ID: 32541321 [Abstract] [Full Text] [Related]
16. Malignant transformation of metastatic giant cell tumor of bone in a patient undergoing denosumab treatment: A case report. Yung D, Asano N, Hirozane T, Yamaguchi S, Mori T, Susa M, Okita H, Morioka H, Horiuchi K, Nakayama R. J Orthop Sci; 2023 Nov 08; 28(6):1492-1496. PubMed ID: 34391616 [No Abstract] [Full Text] [Related]
19. [Clinical, radiologic and pathologic features of giant cell tumor of bone treated with denosumab]. Gong LH, Liu WF, Ding Y, Zhang W, Yang YK, Yu F, Wong GQ, Huang XY, Niu XH. Zhonghua Bing Li Xue Za Zhi; 2018 Jun 08; 47(6):449-454. PubMed ID: 29886590 [Abstract] [Full Text] [Related]